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ABSTRACT 
 
The current study was undertaken to investigate the ability of skeletal tumor cells to intake the heat-killed 
baker’s yeast and the possibility to induce apoptosis of these cells. Cytotoxicity assay was achieved for 
this purpose. Heat-killed Saccharomyces cerevisiae, was cultured with human rhabdomyosarcoma cancer 
cells (RD) and the percent of apoptotic cancer cells was determined by measuring the optical density of 
treated and untreated cancer cells. Upon phagocytosis of yeast, RD cancer cells underwent apoptosis. 
The highest concentration (0.2 mg/ml) of heat-killed yeast gives the highest killing effect on RD cells (56.5 
%) while the second suspension (0.04 mg/ml) showed inhibition rate (44.7%) as compared with the 
control cells. Phagocytic assay was accomplished to find out the ability of RD cancer cells to uptake and 
phagocytize killed yeasts after the co-culture of S. cerevisiae with the RD cells at a ratio of yeast to cancer 
cells 10:1 respectively, showed that RD cells demonstrate 41 % of attachment to yeasts after 4 hours of 
exposure time while the percent of phagocytosis was 32% after 4 hours. Induction of apoptosis in RD 
cancer cells was dose-dependent. 
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1. INTRODUCTION 
 
Apoptosis,or programmed cell death, is a 
mechanism by which cells undergo death in 
response to unrepaired DNA damage, aging 
and abnormal cells [1] the cancer cells are 
characterized by the capacity to evade 
apoptosis in addition to the unlimited 
proliferation and other characters like invasion 
[2] interest in microbe-based approaches for 
cancer therapy which is based on the use of 
microorganisms or their products for the 
treatment of cancer is not new [3]. 
 
William Coley began the first well documented 
use of bacteria and their toxins to treat end 
stage cancers [4]. Apoptosis-based approaches 
for cancer therapy through biotherapy is an 
important alternative way for the conventional 
anticancer therapies. It has been reported that 
some microorganisms display selective 
replication in tumor cells such as many viruses 
[5].The phagocytosis of microorganisms and 
other materials by cells such as monocytes and 
macrophages which resulted in the induction of 
Apoptosis in these cells has been well studied 
[6]. 
 
Several studies indicated the increase of 
apoptosis in cells after phagocytosis of certain 
bacteria e.g. Escherichia coli [6], 
Staphylococcus aureus [7] and Candida 
albicans [8] another studies demonstrated that 
the Breast cancer cell line cells able to 
phagocytise latex beads and fluorescent 
matrigel [9]. Further studies demonstrated 
phagocytosis in nonlymphatic tumor cells such 
as adenocarcinoma cells and epithelial 
carcinomas of the breast [10]. Malignant cells 
that are not phagocytic in origin in cervical 
cancer patients and in vitro showed a 
phagocytic activity against autologous 
lymphocytes [11], aged lymphocytes, bacteria 
and C. albicans [12].  Rhabdomyosarcoma 
(RMS) is a type of cancer which can be 
diagnosed in children and teens, it presents as a 
soft tissue mass commonly developed in head, 
neck, genital and urinary tract. The other type of 
(RMS) which affects people from all ages tend 
to arise in big muscles of legs, arms and trunk. 
Sarcomas in general is the cancer of connective 
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tissues of the body. Rhabdomyosarcoma 
accounts for over 50% of sarcomas in children 
and young People and it originally came from 
cells that normally develop into skeletal 
muscles; this type of cancer unfortunately can 
start at any point of the body [13-15]. It is worth 
mentioning that Rhabdomyosarcoma cell line 
was originally derived from a biopsy specimen 
obtained from a pelvic Rhabdomyosarcoma of a 
7-year-old Caucasian girl [16]. The development 
and search for more effective and safe 
treatment modalities now is a very important 
part of the research studies, trying to avoid the 
serious side effects of radio and chemotherapy.  
The current study aims to examine whether RD 
cells undergo apoptosis post treatment with 
heat-killed Saccharomyces cerevisiae through 
phagocytosis. 
 
2. MATERIALS AND METHODS 
 
2.1. Tumor cell line 
 
Rhabdomyosarcoma (RD) cell line was used in 
the current study; the cell line was thankfully 
supplied by the Iraqi Cancer Center for Medical 
and Genetic Research (ICCMGR).The tumor 
cells were maintained in RPMI medium 
supplemented with 10% fetal bovine serum and 
100 µg/ml streptomycin and penicillin .cells were 
maintained in a humidified Incubator at 37 
ο
C, 
and routinely sub-cultured whenever it reaches 
to a semi-confluent monolayer. 
 
2.2. Preparation of S.cerevisiae 
 
A commercially available baker’s yeast was 
used .yeast suspensions were washed once in 
phosphate buffer saline (PBS) buffer and 
incubated in 90 
ο
C for 1 h to kill the yeast by 
autolysis. The cells were quantified following 
washing using haemocytometer and the yeast 
was adjusted to 1x 10
7
 cells/ml. Yeast solution 
was prepared by dissolving 0.1 g of yeast in 100 
ml D.W. to make the stock solution, then  series 
dilutions were  made by adding serum free 
medium. 
 
2.3. Phagocytic assay 
 
This assay was done according to Ghoneum 
and Gollapudi [17], with slight modification. 
Yeast cells were mixed with tumor cells at 10:1 
ratio (yeast to tumor cells). For this purpose 0.5 
ml of tumor cell culture containing 1x 10
6
 cells 
/ml was mixed with   0.5 ml of yeast suspension 
containing 1 x 10
7
 cells/ml. The mixture was 
centrifuged for 5 min at 50 x g and incubated at 
37 
ο
C for 4 h. Then the mixture was re-
suspended to detach the loosely attached cells. 
Slides were prepared by adding 200 µl of the 
cell suspension. Preparations were fixed in 
100% methanol, air-dried, then stained with 4% 
Giemsa for 15 min and were examined for the 
attachment and uptake of yeast by tumor cells 
using oil immersion x100 in a light microscope. 
The estimation of attachment and uptake of 
yeast by tumor cells was as the following: 
the estimation of attachment of yeast by tumor 
cells was calculated as the percentage of 100 
tumor cells that attached to one or more yeast 
on the other hand the estimation of uptake of 
yeast by tumor cells was calculated as the 
percentage of 100 tumor cells that ingested one 
or more yeast with the following formula:
 
 
The attachment index (AI) was calculated using the following formula: 
 
AI = (% tumor cells attaching to yeast) x (number of yeast per 100 tumor cells) 
       –––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
1000 
 
The uptake of yeast by tumor cells was calculated as the following formula: 
 
PI = (% tumor cells phagocytizing yeast) x (number of yeast per 100 tumor cells) 
       –––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
1000 
 
 
2.4 Apoptotic studies 
 
2.4.1 Detection of the cytotoxic effect of 
yeast lysate on RD cells 
 
A. RD cells were treated with the yeast 
suspensions of the prepared dilutions for 72 
h. While controls cells were cultured in the 
absence of yeast cells. Then the apoptosis 
of the treated tumor cells was observed 
post staining with crystal violet stain. The 
results were obtained by measuring the 
optical density at 450 nm. 
B. Detection apoptosis by morphological 
Analysis: Apoptosis is defined by the cell 
shrinkage, membrane blebbing and 
chromatin condensation due to DNA 
fragmentation these characteristics were 
used to identify the apoptotic cancer cells 
after staining. 
 
2.4.2 Statistical analysis 
 
The Student T-test was used to test the 
significant difference in the percent changes of 
apoptotic cancer cells which treated with yeast 
as compared to cancer cells alone, as well as 
the attachment and uptake of yeast cells by the 
cancer cells. 
 
3. RESULTS AND DISCUSSION 
 
Rhabdomyosarcoma  cells  were  cultured  with  
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heat-killed Saccharomyces cerevisiae (Baker’s 
yeast) in different concentrations for 72 h. The 
results depicted in Figure 1 show that the co-
culture of cancer cells with yeast resulted in a 
significant increase in RD cells inhibition rate 
(death) with the increasing of yeast cells 
concentrations. The figure revealed that 
suspension 1  represents the highest 
concentration (0.2 mg/ml) of heat-killed yeast 
gives the highest killing effect on RD cells 
(56.47%) while the second suspension (0.04 
mg/ml) showed inhibition rate (Cytotoxicity) 
(44.66%)  as compared with the control cells on 
the other hand the last  concentration has the 
minimum effect (15.4%) on RD cells.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  RD cancer cells treatment with heat-killed Saccharomyces cerevisiae suspensions 
 
 
 
  
 
Figure 2. Inhibition of RD cancer cells in vitro after treatment with heat-killed yeast cells; (A) and (B) 
treated with yeast concentrations 0.2 and 0.04 mg/ ml  respectively. 
 
 
Alteration in morphological characteristics of the 
cancer cell line was noticed as shown in Figure 
2 and demonstrates the morphological change 
of cancer cells upon treatment with heat-killed 
yeast appeared rounded, shrunken with cell 
debris as a result of cell lysis and death by 
apoptosis, in comparison with the untreated RD 
cancer cells that seemed as a confluent 
monolayer as shown in Figure 3A and 3B). 
 
Phagocytosis assay was achieved by mixing RD 
cells with yeast in percentage 1:10 respectively 
and the data shows that RD cells demonstrate 
41% of attachment to yeasts after 4 h of 
exposure time while the percent of phagocytosis 
was 32% after 4 h of incubation, and the current 
result agreed with several studies reported that 
the level of attachment of tumor cells to yeasts 
is peaked at 2 h post treatment and it might 
either maintained or declined at 4 h. 
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Figure 3. RD cancer cells untreated with S. cerevisiae: (A) represent RD cell culture as control; (B) RD 
cancer cells as control post staining with crystal violet. 
 
 
 
 
 
Figure 4. Attachment and uptake of S. cerevisiae by RD cancer cells. 
 
 
 
Phagocytosis by different types of cancer cells 
such as leukemia [18], breast cancer [17], colon 
and tongue squamous cell carcinoma [19] and 
other types that exhibit the phagocytic activity 
against  certain materials and microorganisms 
has  been reported in several researches  
[20,21]. Phagocytosis by cancer cells is a 
phenomenon which was originally identified by 
the histological examination of human tumors 
which revealed the presence of intracytoplasmic 
leukocytes, erythrocytes and blood platelets in 
tumor cells [18]. It was hypothesized that the 
tumor cells acquire the ability of phagocytosis 
during the development of malignancy [17]. In 
the phagocytic activity of breast cancer cells 
(BCCs) using yeast as the test organism to 
trigger apoptosis of cancer cells, it was found 
that ergosterol which present in baker’s and 
brewer’s yeast  inhibits the growth of human 
BCCs in vitro by a mechanism that might involve 
oxidation products of ergosterol  [22].  
 
The differences in the apoptosis percentage 
post-phagocytosis of baker’s  yeast  In vitro is 
depending on the type of cancer cell line and 
the capacity of cancer cells to uptake the yeast 
,moreover, it is suggested that the uptake of 
yeast by cancer cells, and not the attachment, 
may induce apoptosis of cancer cells [12]. 
 
RD cells have been shown to exhibit high 
phagocytic activity against yeast with an 
increased level of apoptosis. The mechanisms 
of apoptosis of RD cells post culture with yeast 
is not known, but it is suggested that the 
engulfed yeast could induce apoptosis by a 
mechanism associated with activation of 
caspases 8, 9 and 3 in the cancer cell line. 
 
According to several findings, S. cerevisiae 
induces apoptosis in cancer cells also by a 
caspase-independent mechanism [23]. In 
response to an apoptotic stimulus, many 
mediators are released from mitochondria and 
transfer death signals to the nucleus in a 
caspase-independent manner. These mediators 
include mitochondrial proteins AIF, 
endonuclease G, NADH oxidoreductase and 
mitochondrial repair system enzymes [24]. 
Apoptosis could be triggered by the elevation of 
the intracellular levels of Ca2+ which is a very 
important factor in triggering apoptotic signals 
via mitochondria [12]. 
 
(C) 
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CONCLUSION 
 
In summary, our results show that 
Rabdomyosarcoma cancer cell line has the 
ability to uptake yeasts and undergo apoptosis 
in vitro. The effect was dose-dependent. This 
data may have a safe alternative way for 
targeting cancer cells using non-pathogenic 
yeast (S. cerevisiae) to induce apoptosis in 
cancer cells through phagocytosis process. We 
suggest establishing further studies in yeast-
induced apoptosis as a cancer therapy that 
could have therapeutic implications and it is 
advisable to investigate the molecular 
mechanisms of cell killing as well as the 
enhancement of yeasts by other materials or 
extracts. 
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